VitalConnect, Inc.

VitalConnect, Inc. , headquartered in San Jose, US, specializes in remote patient monitoring solutions, utilizing innovative wearable technology to enhance healthcare delivery and patient outcomes. Founded in 2011, VitalConnect, Inc. offers advanced remote patient monitoring solutions.

The company has completed 13 deals, with its most recent funding round being a Series F on February 19, 2025, raising USD 30. 00 mn, led by Revelation Capital Management. The company has a current valuation of USD 355. 49 mn.

Peter Van Haur serves as CEO. VitalConnect specializes in remote patient monitoring solutions, particularly focusing on its flagship product, the VitalPatch RTM. This innovative technology provides real-time streaming of up to 11 vital signs, including live electrocardiograms (ECG), which allows healthcare providers to monitor patients both in-hospital and during their recovery at home. The VitalConnect Solution is designed to optimize care delivery and enhance patient outcomes, especially for those recovering from COVID-19, while simultaneously reducing caregiver exposure.

By leveraging telehealth-enabled software, VitalConnect addresses critical use cases in chronic disease management and cardiac monitoring. The company's products are primarily deployed in the United States and are being adopted in various healthcare settings, including hospitals and home care environments, catering to healthcare professionals and patients alike. VitalConnect's revenue model is largely derived from its subscription-based services and partnerships with healthcare organizations. Clients, including hospitals and telehealth providers, typically engage with the company to integrate the VitalConnect Solution into their care protocols.

Under this model, healthcare institutions may pay for the deployment of the VitalPatch RTM, which includes access to real-time monitoring capabilities and data analysis tools. Transactions often encompass service agreements that ensure ongoing support and software updates, enabling healthcare providers to maintain a high standard of patient monitoring. While specific pricing plans for individual products and services are not disclosed, the company’s offerings are structured to facilitate scalability and adaptability within diverse healthcare settings. In February 2025, VitalConnect, Inc.

raised a part of a USD 100 mn equity and venture debt funding round, led by new investor Ally Bridge Group, with significant participation from returning investors EW Healthcare Partners, MVM, and Revelation Capital Management. The funding will be utilized to increase VitalConnect's commercial footprint and make its life-saving technology available to more patients. The company is focused on expanding its product line and introducing new products, although specific details on upcoming releases are not disclosed. VitalConnect aims to target additional geographic markets to broaden its reach and enhance its service delivery.